Neurological diseases
Neurological diseases encompass a wide range of conditions affecting the brain, spinal cord, and nervous system. These include well-known neurodegenerative diseases such as Parkinson’s and Alzheimer’s disease, as well as other neurological disorders that affect patients’ daily lives and long-term health. Due to ageing populations and increasing disease complexity, neurological diseases are a growing health challenge in Luxembourg and throughout the world.
At the Luxembourg Research Clinic (LRC), clinicians, researchers and healthcare professionals work closely together to improve the understanding, diagnosis and treatment of neurological conditions. The goal is to support earlier diagnosis, more personalised care and better outcomes for patients. The various programmes and studies give patients access to advanced clinical studies, supported by expertise in diagnostics, imaging, and care.
Diseases we study:
- Parkinson’s disease and atypical parkinsonisms
- Alzheimer’s disease and other dementias
- Multiple Sclerosis
- Brain cancer & metastasis
“
Today, by bringing research and patient care closer together, we can detect neurological diseases earlier and develop more effective treatments that make a real difference to people’s lives”
Prof. Dr Rejko Krüger, Coordinator of the National Centre of Excellence for Research on Parkinson’s disease (NCER-PD)
Coordinator
Institutional contact points
Related programmes
ParkinsonNet Luxembourg
Neurological diseases Parkinson’s disease affects many aspects of daily life and can cause a wide range of symptoms that differ from one person to another. As a…
pdp – Programme Dementia Prevention
The Programme Dementia Prevention (pdp) is a national initiative supporting people who are experiencing mild changes in their memory or thinking, such as Subjective Cognitive…
NCER-PD
The National Centre of Excellence in Research on Parkinson’s Disease (NCER-PD) is a long-term research programme dedicated to improving the understanding, diagnosis, and treatment of…
Related studies
Protected: REPHLECS-PD
36+ years REPLHECS-PD aims to improve the detection and monitoring of orthostatic hyperotension in people with Parkinson's disaese through the usage of wearable devices.
DMDEmpower
DMDEmpower Study is assessing the empowering capabilities of people living with Parkinson’s disease in the digital health era in Luxembourg and the Greater Region of…
Clinnova-MS
Multiple sclerosis (MS) is a chronic neurological condition that can affect people in very different ways. The Clinnova-MS project aims to improve personalised care for…
LuxPark
The Luxembourg Parkinson's Study is a cohort study that aims to improve the understanding of Parkinson's disease and related movement disorders.
Related news
Luxembourg Research Clinic was launched during the Clinical Research Conference to strengthen patient access to clinical research
On September 29, the Luxembourg Institute of Health (LIH) and its national partners officially inaugurated the Luxembourg Research Clinic (Fuerschungsklinik…
Small country, significant capacity
Luxembourg may be one of Europe’s smallest countries, but the Luxembourg Research Clinic demonstrates how its highly connected national network…
Clinnova Consortium Agreement signed, marking a major milestone for health research across Europe
Thanks to a joint investment from LIH and the Ministry of Health, the national biobank accessible to LRC studies has…
Upcoming events
Clinical Research Luxembourg Conference
Why does clinical research matter today in Luxembourg? Clinical research plays a vital role in improving patient care, driving medical…
Impact of Big Data & AI analytics on healthcare
This year, the Luxembourg Centre for Systems Biomedicine (LCSB)'s annual conference will take place on 19–20 November 2026 at the Maison…